14TH NATIONAL CONGRESS OF THE COMMUNIST PARTY OF VIETNAM

Second made-in-Vietnam COVID-19 vaccine to begin human trials after Tet

Anh Kiet

Jan 20, 2021 / 08:31 PM

Covivac will be the second made-in-Vietnam vaccine to be tested on humans after Nanocovax.

A second Covid-19 vaccine developed by Vietnam, Covivac, is scheduled to be tested on humans after Tet holiday, the Ministry of Health (MoH) said on January 19.

Covivac, produced by the Institute of Vaccines and Medical Biology (IVAC), yesterday received approval from the MoH for human trials.

Covivac will be the second made-in-Vietnam vaccine to be tested on humans after the Nanogen Pharmaceutical Biotechnology JSC (NANOGEN) began trials last December of its Nanocovax.

Nanocovax, produced by the Nanogen Pharmaceutical Biotechnology JSC, was Vietnam's first coronavirus vaccine to enter human trials. Photo: Kinhtedothi.vn

The first phase of the trials will require 120 volunteers aged 18-59 and without underlying health conditions, infectious diseases or allergies, the health ministry said.

The ministry added that the IVAC will coordinate with the National Institute of Hygiene and Epidemiology in Hanoi and the Hanoi Medical University to begin recruiting volunteers and prepare equipment and facilities for the trials since January 21.

The volunteers will receive the first shot after Vietnam’s traditional Lunar New Year, in mid-February. The second phase is expected to begin in April and the third in July or August.

According to Dr. Chu Van Men, director of Center for Clinical Trials and Bioequivalence under the Military Medical University’s, Vietnam expects to collect all necessary data on clinical testing by the end of 2021 before it can consider mass vaccination.

Vietnam’s health ministry is in talks with the UK Covid-19 vaccine developers AstraZeneca and Oxford University to buy 30 million doses. It is also seeking to buy from the US (Pfizer), Russia (Sputnik V) and China.

Vietnam to test highest dose of Covid-19 vaccine

12 Jan, 20:42

Nanocovax vaccine produced by NANOGEN Company is the first made-in-Vietnam Covid-19 vaccine which is undergoing clinical trial in humans.

From which partners will Vietnam buy Covid-19 vaccine?

08 Jan, 17:37

Vietnam’s Ministry of Health is working hard to ensure Vietnamese people will soon access the Covid-19 vaccines.

Vietnam starts injection of made-in-Vietnam Covid-19 vaccine on humans

18 Dec, 17:25

In the morning of December 17, the Military Medical Academy gave the first test dose of Covid-19 Nano Covax vaccine on volunteers. This is the first phase of the COVID-19 vaccine clinical trial program in Vietnam.

Hanoi ready to host first edition of Miss Multicultural World

Hosting the competition is seen as an opportunity for Hanoi to promote its image and demonstrate its capacity to hold world-class beauty events.

05 Feb, 07:56 AM

Vietnamese workers prioritise wellbeing over pay: survey

Wellbeing is overtaking pay as a key priority for Vietnamese workers, led by Gen Z’s push for healthier, more transparent workplaces, redefining job stability and reflecting cautious labor movement as the market waits for stronger momentum beyond 2025.

03 Feb, 05:36 PM

Technology driven ideas focus on preventing traffic dangers early

Rooted in everyday experience, emerging initiatives use practical technologies to identify risks early and encourage safer behavior on the roads.

02 Feb, 10:27 PM

Happiness Train spreads human values and promotes Vietnam tourism

Vietnam’s “Happiness Train” departed Hanoi on February 2, turning a regular rail journey into a moving cultural space that promotes shared values, social connection and national tourism ahead of Tet.

02 Feb, 09:55 PM

ASEAN Eco-Schools Awards 2025 honors 60 Vietnamese schools nationwide

The ASEAN Eco-Schools Vietnam Awards 2025 marked a nationwide effort to promote plastic waste-free campuses, recognizing exemplary education institutions for integrating sustainability, environmental responsibility and green practices into teaching, learning and daily school operations.

01 Feb, 09:08 AM